Dr. Luigina Romani
Biography & Research Background
Luigina Romani, MD, PhD, is Professor at the University of Perugia, Italy. She uncovered the critical TLR9-mediated IDO1 activation mechanism by which Thymosin Alpha 1 induces immune tolerance via tryptophan catabolism and regulatory T cell generation. Her 2004 Blood paper on TLR signaling and 2006 Blood paper on IDO1/kynurenine pathways defined the dual immune activation/tolerance paradigm. She also led groundbreaking research on T alpha 1 for cystic fibrosis (Nature research compound, 2017) and antifungal immunity. Luigina Romani is being referenced as one of the leading scientists involved in the research and development of Thymosin Alpha 1. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Luigina Romani is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Luigina Romani is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.